One health care issue about which the presidential candidates acknowledge they have differences is how the health care system should treat people with pre-existing health conditions. People who have a health condition (such as an illness or pregnancy) or who are at higher than average risk of needing health care…
- view as grid
- view as list
This Policy Insight take a deeper look at several key measures of the impact of the current Ebola epidemic in West Africa, including estimates of current cases, prevalence and death rates, as well as a consideration of the future projections of Ebola’s burden in the months to come.
This fall a new rule takes effect requiring all private health plans to offer a uniform, simple to read, summary of benefits and coverage (SBC). The SBC will provide consumers with standardized information about how plans cover essential health benefits and what coverage limits and cost sharing applies. The SBC…
One year into initial enrollment in the Medicare-Medicaid financial alignment demonstrations for dual eligible beneficiaries, some initial insights are beginning to emerge. This policy insight highlights key challenges and trends emerging in states’ demonstrations.
As of August 14, 2014, the Ebola virus has infected an estimated 1,975 individuals across four countries in West Africa, leading to 1,069 deaths (including three Americans). The official reported numbers, frightening as they are, likely vastly underestimate the true magnitude of the outbreak. Ebola has severely impacted the daily…
This policy insight examines the unexpected drop in Medicare’s per-beneficiary spending projections and its implications for beneficiaries and the program’s future.
This Policy Insight draws on the experiences of Medicare beneficiaries during Medicare’s annual enrollment period to consider whether consumers with health insurance coverage through the Affordable Care Act’s new marketplaces will shop for a better deal during their open enrollment season.
This Policy Insight outlines eight questions that are likely to shape the U.S. global health response in the last two years of the current presidential term and beyond.